Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chin Lee
A 52-Week, Open-Label Study Evaluating the Safety and Efficacy of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, for Rheumatoid Arthritis
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Radiographic Progression of Structural Joint Damage in Patients With Active Psoriatic Arthritis Treated With Ixekizumab Over 52 Weeks
SKIN The Journal of Cutaneous Medicine
Related publications
Efficacy and Safety of Subcutaneous Tabalumab, a Monoclonal Antibody to B-Cell Activating Factor, in Patients With Systemic Lupus Erythematosus: Results From ILLUMINATE-2, a 52-Week, Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain
Current Oncology
Oncology
SAT0236 Long-Term Safety and Efficacy of Upadacitinib (ABT-494), an Oral Jak-1 Inhibitor in Patients With Rheumatoid Arthritis in an Open Label Extension Study
Anti-CCP Antibody and Rheumatoid Factor Positivity in a Case of Tuberculosis Arthritis
Turkish Journal of Rheumatology
Safety and Efficacy of Tofacitinib for Up to 9.5 Years in the Treatment of Rheumatoid Arthritis: Final Results of a Global, Open-Label, Long-Term Extension Study
Arthritis Research & Therapy
Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia
Journal of Child and Adolescent Psychopharmacology
Mental Health
Child Health
Pharmacology
Perinatology
Psychiatry
Pediatrics
Efficacy and Safety of an Intravenous Monoclonal Anti-HBs in Chronic Hepatitis B Patients
Liver International
Hepatology
B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics